Buprenorphin-Mepha 35ug/h

Buprenorphin-Mepha 35ug/h is a medicine authorised by Swissmedic under authorisation number 65809. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 19 May 2015 and the authorisation is valid without a time limit. ATC code N02AE01 places the medicine in the group Analgesics.

  • Dispensing category A+
  • Authorisation number 65809
  • ATC N02AE01
  • Synthetic medicines
Authorisation data
Authorisation number65809
NameBuprenorphin-Mepha 35ug/h
Full nameBuprenorphin-Mepha 35ug/h, Transdermale Pflaster
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codeN02AE01
First authorisation19 May 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Buprenorphin-Mepha 35ug/h, Transdermale PflasterA+19 May 2015
2Buprenorphin-Mepha 52.5 ug/h, Transdermale PflasterA+19 May 2015
3Buprenorphin-Mepha 70 ug/h, Transdermale PflasterA+19 May 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
74PflasterN02AE0101.01.3.A+
88PflasterN02AE0101.01.3.A+
94PflasterN02AE0101.01.3.A+
108PflasterN02AE0101.01.3.A+
114PflasterN02AE0101.01.3.A+
128PflasterN02AE0101.01.3.A+

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Buprenorphin-Mepha 35ug/h authorised in Switzerland?

Yes. Buprenorphin-Mepha 35ug/h is authorised by Swissmedic under authorisation number 65809, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Buprenorphin-Mepha 35ug/h have?

Buprenorphin-Mepha 35ug/h is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Buprenorphin-Mepha 35ug/h?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com